NCT04684004

Brief Summary

Patients with Takotsubo cardiomiopathy (TTC) have over-inflammation and over-sympathetic tone. However, these conditions could cause higher rate of heart failure (HF) events and deaths at 2 years of follow-up. Conversely, hyperglycemia vs. normoglycemia could result in over expression of inflammatory markers and catecholamines thta could result in higher rate of HF and deaths at 2 years of follow-up in TTC patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 24, 2020

Completed
Last Updated

December 28, 2020

Status Verified

December 1, 2020

Enrollment Period

4 years

First QC Date

December 22, 2020

Last Update Submit

December 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The number of HF events

    To evaluate the number of HF events by clinical visits, telephonic interviews and hospital discharge schedules.

    12 months

Study Arms (2)

TTC patients with hyperglycemia

These patients will be hospitalized for TTC acute event. These patients will be characterized by higher blood glucose values at admission, and so defined as hyperglycemics.

Other: To report number of HF events and deaths

TTC patients with normoglycemia

These patients will be hospitalized for TTC acute event. These patients will be characterized by normal blood glucose values at admission, and so defined as normoglycemics.

Other: To report number of HF events and deaths

Interventions

In these two cohorts of study authors will evaluate at 2 years of follow-up the number of HF events and of deaths.

TTC patients with hyperglycemiaTTC patients with normoglycemia

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will be of patients with acute TTC event. The enrolled patients according to inclusion and exclusion criteria will be then divided in normoglycemics vs. hyperglycemics according to blood glucose values at hospital admission.

You may qualify if:

  • acute onset of a cardiovascular event, usually associated with substernal chest pain, initially regarded as STEMI/evolving coronary syndrome;
  • cardiac biomarker modifications (creatine kinase-MB and troponin I);
  • systolic dysfunction, predominantly characterized by akinesia/hypokinesia of the mid-to-distal portion of the left ventricle (LV) chamber, with hyper-contractile basal LV.

You may not qualify if:

  • patients with previous previous myocardial infarction;
  • patients with previous TTC event;
  • patients affected by chronic kidney, liver, and cerebrovascular diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Raffaele Marfella

Naples, 80138, Italy

Location

Related Publications (1)

  • Paolisso P, Bergamaschi L, Rambaldi P, Gatta G, Foa A, Angeli F, Fabrizio M, Casella G, Barbieri M, Galie N, Marfella R, Pizzi C, Sardu C. Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators. Diabetes Care. 2021 Sep;44(9):2158-2161. doi: 10.2337/dc21-0433. Epub 2021 Jun 29.

MeSH Terms

Conditions

Takotsubo Cardiomyopathy

Interventions

Death Domain

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesVentricular Dysfunction, LeftVentricular Dysfunction

Intervention Hierarchy (Ancestors)

Death Domain SuperfamilyProtein Interaction Domains and MotifsProtein DomainsProtein Structural ElementsProtein ConformationMolecular ConformationMolecular StructureBiochemical PhenomenaChemical Phenomena

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
researcher

Study Record Dates

First Submitted

December 22, 2020

First Posted

December 24, 2020

Study Start

January 1, 2013

Primary Completion

January 1, 2017

Study Completion

January 1, 2019

Last Updated

December 28, 2020

Record last verified: 2020-12

Locations